NEW! Investment Companies Centre
- Login to your account
- Free Membership to Digital Look
- Site Map
- Company A-Z
- Finance A-Z
- News Archive
- Events
- Give Us Feedback
Digital Look
- Company A-Z
- Company Search
- MarketStars Premium
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Mobile Tools / PDA
- Education Guides
- UK Shares
- Investment Companies
- Funds
- International Shares
- Bonds
- Currencies
- Commodities
- Covered Warrants
Virgin Credit Card:
Market Cap
£7.26m
Change Today
0.000p ()
Share Price
2.50p
Directorate Change
29 September 2008
Embargoed, 0701hrs
Journey Group plc
(the "Company")
Appointment of New Director
The Company is pleased to announce the appointment of Gijs de Reuver as Non-executive Director with immediate effect.
Gijs de Reuver has been a partner with Cycladic Capital since 2004 which invests in small and mid sized public companies across Europe. Prior to joining Cycladic Capital, he worked for Houlihan Lokey Howard & Zukin advising companies and creditors on financial restructuring, for Goldman Sachs advising on mergers, acquisitions and financing and for Arthur D. Little as a strategy consultant. Gijs de Reuver holds an MSc in electronics from Delft University of Technology and an MBA from the University of Chicago Graduate School of Business.
For further information please contact:
|
Journey Group plc |
Tel: 44 (0) 20 8606 2000 |
|
Stephen Yapp, Executive Chairman |
|
|
Carl Fry, Interim Chief Financial Officer |
|
|
|
|
|
Tavistock Communications |
Tel: +44 (0) 20 7920 3150 |
|
Jeremy Carey |
|
|
Matt Ridsdale |
|
|
|
|
|
KBC Peel Hunt Ltd (Nominated Adviser & Broker) |
Tel: +44 (0) 20 7418 8900 |
|
Oliver Scott |
|
|
David Anderson |
|
Additional information
Gijs Jan Pancras de Reuver (aged 41) holds, or has in the last five years held, the following directorships and/or partnerships:
|
Current directorships/partnerships |
Former directorships/partnerships held within the last 5 years |
|
Cycladic Capital LLP |
Mellen Limited |
There is no further information in respect of the above appointment required to be disclosed pursuant to paragraph (g) of Schedule 2 to the AIM Rules for Companies.
This information is provided by RNS